ENSUVIQ Trademark

Trademark Overview

On Friday, July 15, 2022, a trademark application was filed for ENSUVIQ with the United States Patent and Trademark Office. The USPTO has given the ENSUVIQ trademark a serial number of 97505378. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, July 31, 2024. This trademark is owned by Aytu BioPharma, Inc.. The ENSUVIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of connective tissue disorders
ensuviq

General Information

Serial Number97505378
Word MarkENSUVIQ
Filing DateFriday, July 15, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, July 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of connective tissue disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAytu BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDenver, CO 80237
Party NameAytu BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEnglewood, CO 80129

Trademark Events

Event DateEvent Description
Tuesday, July 19, 2022NEW APPLICATION ENTERED
Monday, May 1, 2023ASSIGNED TO EXAMINER
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 1, 2024SOU EXTENSION 1 FILED
Thursday, March 7, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, March 7, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, March 7, 2024PETITION TO REVIVE-GRANTED
Thursday, March 7, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, August 1, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 4, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, March 4, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, March 7, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, March 7, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, April 17, 2024SOU EXTENSION 1 GRANTED
Wednesday, July 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024SOU EXTENSION 2 GRANTED
Wednesday, July 31, 2024SOU EXTENSION 2 FILED
Thursday, April 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 15, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

ensuviq tissue disorders connective treatment preparations pharmaceutical